Balchem (NASDAQ:BCPC) Upgraded at StockNews.com

StockNews.com upgraded shares of Balchem (NASDAQ:BCPC) from a hold rating to a buy rating in a research note released on Tuesday.

BCPC has been the subject of a number of other reports. Sidoti upgraded shares of Balchem to a “hold” rating in a report on Tuesday, February 25th. HC Wainwright set a $180.00 price objective on Balchem and gave the company a “buy” rating in a research report on Monday, April 28th.

Balchem Trading Up 2.3%

Shares of Balchem stock opened at $167.11 on Tuesday. The business has a fifty day simple moving average of $161.71 and a 200-day simple moving average of $166.37. Balchem has a fifty-two week low of $145.70 and a fifty-two week high of $186.03. The firm has a market cap of $5.45 billion, a price-to-earnings ratio of 42.52, a price-to-earnings-growth ratio of 4.41 and a beta of 0.93. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19.

Balchem (NASDAQ:BCPC) last issued its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing analysts’ consensus estimates of $1.25 by ($0.03). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The business had revenue of $250.52 million during the quarter, compared to analyst estimates of $245.70 million. During the same period in the previous year, the company posted $1.03 earnings per share. Balchem’s revenue was up 4.5% compared to the same quarter last year. On average, equities analysts forecast that Balchem will post 4.64 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Covestor Ltd lifted its position in shares of Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock valued at $26,000 after acquiring an additional 76 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Balchem in the fourth quarter valued at $29,000. Federated Hermes Inc. acquired a new stake in shares of Balchem in the fourth quarter worth $33,000. Versant Capital Management Inc boosted its position in shares of Balchem by 534.2% in the first quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company’s stock worth $40,000 after buying an additional 203 shares during the period. Finally, SVB Wealth LLC purchased a new position in shares of Balchem during the first quarter valued at $57,000. 87.91% of the stock is currently owned by institutional investors and hedge funds.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.